CN107319524A - A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN107319524A CN107319524A CN201710516559.3A CN201710516559A CN107319524A CN 107319524 A CN107319524 A CN 107319524A CN 201710516559 A CN201710516559 A CN 201710516559A CN 107319524 A CN107319524 A CN 107319524A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- nephrosis
- clinical nutrition
- tailored version
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 41
- 230000035764 nutrition Effects 0.000 title claims abstract description 38
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims description 29
- 208000009928 nephrosis Diseases 0.000 title claims description 27
- 231100001027 nephrosis Toxicity 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000009472 formulation Methods 0.000 title abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 105
- 229940088594 vitamin Drugs 0.000 claims abstract description 41
- 229930003231 vitamin Natural products 0.000 claims abstract description 41
- 235000013343 vitamin Nutrition 0.000 claims abstract description 41
- 239000011782 vitamin Substances 0.000 claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 34
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 33
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 27
- 244000068988 Glycine max Species 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 230000035622 drinking Effects 0.000 claims abstract description 24
- 235000008216 herbs Nutrition 0.000 claims abstract description 24
- 230000010354 integration Effects 0.000 claims abstract description 24
- 235000015097 nutrients Nutrition 0.000 claims abstract description 23
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 21
- 241000196324 Embryophyta Species 0.000 claims abstract description 17
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 244000268590 Euryale ferox Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 15
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 15
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 14
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 13
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 235000013305 food Nutrition 0.000 claims abstract description 13
- 235000012054 meals Nutrition 0.000 claims abstract description 13
- 239000011573 trace mineral Substances 0.000 claims abstract description 12
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 12
- 241000237502 Ostreidae Species 0.000 claims abstract description 9
- 235000020636 oyster Nutrition 0.000 claims abstract description 9
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000003094 microcapsule Substances 0.000 claims abstract description 7
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 5
- 235000013350 formula milk Nutrition 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 235000018102 proteins Nutrition 0.000 claims description 21
- 108010038807 Oligopeptides Proteins 0.000 claims description 19
- 102000015636 Oligopeptides Human genes 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 10
- 241000251468 Actinopterygii Species 0.000 claims description 9
- -1 phytosterol Chemical compound 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 7
- 235000004347 Perilla Nutrition 0.000 claims description 7
- 244000124853 Perilla frutescens Species 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 235000013601 eggs Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 2
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- 240000002547 Rosa roxburghii Species 0.000 claims description 2
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 235000010081 allicin Nutrition 0.000 claims description 2
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 2
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 2
- 235000020243 first infant milk formula Nutrition 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 2
- 229960002442 glucosamine Drugs 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 235000012680 lutein Nutrition 0.000 claims description 2
- 229960005375 lutein Drugs 0.000 claims description 2
- 239000001656 lutein Substances 0.000 claims description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 2
- 235000012661 lycopene Nutrition 0.000 claims description 2
- 229960004999 lycopene Drugs 0.000 claims description 2
- 239000001751 lycopene Substances 0.000 claims description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 210000004885 white matter Anatomy 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 6
- 238000012216 screening Methods 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 208000020832 chronic kidney disease Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 229920002774 Maltodextrin Polymers 0.000 description 10
- 239000005913 Maltodextrin Substances 0.000 description 10
- 240000007651 Rubus glaucus Species 0.000 description 10
- 229940035034 maltodextrin Drugs 0.000 description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 10
- 239000005862 Whey Substances 0.000 description 9
- 102000007544 Whey Proteins Human genes 0.000 description 9
- 108010046377 Whey Proteins Proteins 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 235000019688 fish Nutrition 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 235000013312 flour Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000004006 olive oil Substances 0.000 description 7
- 235000008390 olive oil Nutrition 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 235000010489 acacia gum Nutrition 0.000 description 6
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- 241000972773 Aulopiformes Species 0.000 description 5
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 5
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 229920001503 Glucan Polymers 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 240000003183 Manihot esculenta Species 0.000 description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 244000062793 Sorghum vulgare Species 0.000 description 5
- 240000004922 Vigna radiata Species 0.000 description 5
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 5
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000021277 colostrum Nutrition 0.000 description 5
- 210000003022 colostrum Anatomy 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 5
- 235000019713 millet Nutrition 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 235000019515 salmon Nutrition 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 229960003080 taurine Drugs 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 235000008939 whole milk Nutrition 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- 241000206575 Chondrus crispus Species 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 4
- 229940029339 inulin Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 235000019710 soybean protein Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 239000011647 vitamin D3 Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical group SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 208000033679 diabetic kidney disease Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003132 food thickener Nutrition 0.000 description 2
- 206010061989 glomerulosclerosis Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 235000020905 low-protein-diet Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 206010018372 Glomerulonephritis membranous Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010055171 Hypertensive nephropathy Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241000408747 Lepomis gibbosus Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 240000003186 Stachytarpheta cayennensis Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 231100000852 glomerular disease Toxicity 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000003552 inferior colliculi Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000008350 membranous glomerulonephritis Diseases 0.000 description 1
- 231100000855 membranous nephropathy Toxicity 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000011617 nephropathy animal model Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000020236 pumpkin seed Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000012959 renal replacement therapy Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention relates to a kind of nephrotic's tailored version clinical nutrition formula, it includes 8 15 parts of protein, 8 12 parts of fat, 55 65 parts of carbohydrate, 35 parts of dietary fibers, 0.5 1.5 parts of part macroelements, 0.01 0.04 parts of part trace elements, 0.005 0.015 parts of liposoluble vitamins, 0.01 0.2 parts of water soluble vitamins, 0.05 1 parts of meals elite, 0.05 2 parts of integration of drinking and medicinal herbs compositions, 0.1 3 parts of natural plants compounds and 0.005 2 parts of new resource foods, wherein integration of drinking and medicinal herbs composition is selected from Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon fruit, Chinese yam, at least one of oyster;Above-mentioned each component is previously prepared into powder, wherein fat and vitamin are prepared into powder using micro-capsule embedding techniques.Screening and proportioning by said components, nutrient formulation of the present invention provides more reasonable, comprehensive nutritional support for nephrotic, to improve the condition of nephrotic, the composition of nourishing liver and kidney, strengthening the essence blood-nourishing and strengthen immunity is added simultaneously, delay progression of disease, improve the quality of living, extend the life-span.
Description
Technical field
The present invention relates to special medicine purposes formula food field, and in particular to a kind of nephrosis tailored version clinical nutrition formula
And preparation method thereof.
Background technology
Kidney is the vitals in human body with excretion, metabolism and endocrine function, and it can be each histoorgan of human body
The metabolic waste of various metabolites, particularly protein produced by metabolic process, is excreted by urine, is maintained
The balance of human body water, electrolyte and soda acid, therefore, kidney is to having very important effect to body metabolism.
Nephrosis refers to clinically various acute and chronic kidney troubles and secondary to acute and chronic caused by other systems disease
Renal dysfunction is until renal failure.Clinically common mainly chronic kidney disease (CKD) patient.No matter chronic kidney disease refers to
Which kind of reason, simply by the presence of renal damage or decreased renal function, and the duration was more than 3 months, and all diagnosable is chronic kidney
Disease.CKD includes primary and Secondary cases kidney trouble, such as various renal glomerular diseases, latent nephritis, pyelonephritis, anaphylaxis
Purpura ephritis, lupus erythematosus nephritis, gout kidney, IgA nephrosis, nephrotic syndrome, membranous nephropathy, nephrotic syndrome, diabetogenous nephrosis
Disease, hypertensive nephropathy, polycystic kindey etc..
In CKD early stages, patient will not generally show any obvious symptom, but in CKD late periods, patient it is possible that
Following sings and symptoms:Number of micturitions increase, especially at night;Physical efficiency level declines;Notice can not be concentrated;Appetite is poor;
Nausea and vomiting;Trick swelling;Dry skin, itch;Dyscoimesis;Muscle cramp, especially at night.CKD is generally in progress
Slowly, it is and usually irreversible.Diabetes especially type II diabetes (T2DM) and hypertension are two of CKD main
Reason.
In recent years, with aging population progress faster, the incidence of disease and the illness rate increase of various kidney troubles, CKD exist
It is distributed in global range, maintains essentially in annual growth 7%-8%.It is estimated that the illness rate in more than 30 years old crowd is
7.2%.
At present, for the treatment of chronic kidney disease, mainly including such as haemodialysis, peritonaeum of drug therapy, renal replacement therapies
Dialysis, kidney transplant etc..The expense of these treatments is greatly increased, and brings serious economy and social concern.
2001, NKF delivered detection and guideline of prevention and treatment, the kidney trouble of chronic renal disease progress
Quality of life instructs (K/KOQI), proposes the integrated therapeutic theory of chronic renal disease, including delays kidney trouble progress, subtracts
The complication such as few cardiovascular complication, reduction malnutrition, anaemia, hypertension, osteopathy, improve survival rate, quality of life and society
What can be lived returns to rate.In the theory of integrated therapeutic, there are the multinomial and nutrition such as reasonable diet, control blood pressure, reduction blood fat
The relevant content for the treatment of, it was confirmed that status of the nutrition treatment in the complex treatment of chronic renal disease.
Therefore, in addition to by correct clinical treatment, rational diet, which coordinates, can delay progression of disease, improve life matter
Amount, extends the life-span.Therefore, develop can provide basal nutrient needed for nephrotic it is plain while, and can supplement to improve and treat
The product of effect, with important value and wide market.
The content of the invention
It is an object of the invention to overcoming defect of the prior art to be formulated there is provided a kind of nephrosis tailored version clinical nutrition and
Its preparation method, it reduces Urine proteins by the nutrition treatment of low protein diet, reduces serium inorganic phosphorus, slow down glomerulosclerosis, simultaneously
Nourishing liver and kidney, strengthening the essence blood-nourishing the integration of drinking and medicinal herbs composition of addition, so as to delay the development and deterioration of the state of an illness, improves patient vitals' matter
Amount, mitigates family and burden on society.
To achieve the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of nephrosis tailored version clinical nutrition formula, including following component and its parts by weight:
8-15 parts of protein, 8-12 parts of fat, 55-65 parts of carbohydrate, 3-5 parts of dietary fibers, 0.5-1.5 parts of macroelements,
0.01-0.04 parts of trace elements, 0.005-0.015 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins, 0.05-1 parts
Meals elite, 0.05-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods;Its
In, the integration of drinking and medicinal herbs composition in Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon fruit, Chinese yam, oyster extremely
Few one kind;Wherein, the protein includes the small protein that mean molecule quantity is below 1000D.
In order to further optimize above-mentioned technical proposal, the technical measures that the present invention is taken also include:
Preferably, the protein be selected from PURE WHEY, hydrolysis Isin glue collagen, soybean protein isolate, whole milk powder,
At least one of dried whole-egg, lactoferrin, colostrum, amino acid, protein peptides;
Wherein, the amino acid is selected from 1B-Pidolidone, Pidolidone, L-arginine, L-Trp, L- paddy
At least one of glutamine, taurine, Valine, ILE, L-Leu;The protein peptides are selected from soy oligosaccharides
At least one of peptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide, laughable peptide, amino peptide, ovalbumin peptide.
Preferably, the small protein is of animal or plant nature oligopeptide, and it includes soybean oligopeptide and marine fish is oligomeric
Peptide.
It is highly preferred that the protein includes PURE WHEY, whole milk powder, dried whole-egg, colostrum, taurine, soybean
Oligopeptide, ocean fish oligopeptide.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide, more specifically it is described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, olive oil, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm
Oil, butter, cream, lard, medium chain triglyceride, lecithin, Purple Perilla Seed Oil etc.;More preferably olive oil, soybean oil, coconut
Oil, perilla herb oil, medium chain triglyceride.
Preferably, the carbohydrate includes fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch, jade
At least two in rice starch;More preferably maltodextrin, tapioca, cornstarch.
Preferably, the dietary fiber comprising inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one of soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber;It is highly preferred that the dietary fiber is water solubility
Dietary fiber, it at least includes bag galactooligosaccharide and oligoisomaltose.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate
At least one of with magnesium gluconate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one of sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, vitamin
K1At least one of.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin
At least one of C, pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;The cereal is selected from rice meal, millet powder, black rice flour, coixlacrymajobi powder, corn
At least one of powder, wheat germ powder, oatmeal, buckwheat;The beans is selected from peameal, mung bean flour, black bean powder, red bean
At least one of powder, soy meal;The potato class is mainly made up of common yam rhizome powder;The Vegetable powder is selected from carrot meal, white radish powder, south
At least one of melon powder, spinach powder, tomato meal, broccoli powder, balsam pear powder;The Homonemeae be selected from mushroom powder, Kelp Powder and
At least one of white fungus powder;The nut-seed class is selected from least one of pumpkin seed powder and lotus nut starch;The fish and shrimp
Selected from least one of salmon powder and cod meal;The poultry meat in chicken meal, powdered beef and pig kidney powder extremely
Few one kind;The fruits are selected from least one of red date powder, longan powder, apple powder, cherry powder, citrus powder, pyrus nivalis powder;More
Preferably millet powder, mung bean flour, white fungus powder, broccoli powder, salmon powder.
Preferably, the integration of drinking and medicinal herbs composition is selected from Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon euryale
At least one of reality, Chinese yam, oyster;More preferably selected from Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon fruit,
Chinese yam.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, plant
At least one of sterol, lycopene, resveratrol, allicin;More preferably l-cn.
Preferably, the new resource food is selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo
In leaf flavones, CPP, avenabeta glucosan, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii, xylo-oligosaccharide
At least one;More preferably avenabeta glucosan.
Preferably, the parts by weight of the of animal or plant nature oligopeptide are 0-1 parts.
Preferably, the fat contains 0-2 parts of Purple Perilla Seed Oil, 2-4 parts of medium chain triglyceride
Preferably, the parts by weight of each component are as follows in the integration of drinking and medicinal herbs composition:0~1 part of Fermented Soybean, Poria cocos 0~1
Part, 0~1 part of raspberry, 0~1 part of matrimony vine, 0~1 part of sealwort, 0~1 part of balloonflower root, 0~1 part of Gorgon fruit, 0~1 part of Chinese yam, oyster 0
~1 part;More preferably 0.01~1 part of Fermented Soybean, 0.01~1 part of Poria cocos, 0.01~1 part of raspberry, 0.01~1 part of matrimony vine, yellow
0.01~1 part of essence, 0.01~1 part of balloonflower root, 0.01~1 part of Gorgon fruit, 0.01~1 part of Chinese yam.
On the other hand, the present invention also provides a kind of preparation method method of above-mentioned nephrosis tailored version clinical nutrition formula, its
Comprise the following steps:
Step 1) fat powder, liposoluble vitamin powder and water soluble vitamin powder are prepared using micro-capsule embedding techniques
End;
Step 2) integration of drinking and medicinal herbs component powders are prepared using crushing, alcohol extracting, water extraction, spray drying and sifting step;
Step 3) protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals are smart
China, natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;
Step 4) by step 1)-step 3) and obtained by powder sequentially add mixer it is well mixed after formula mixing is made
Thing, it is standby after sterilization processing;
Step 5) according to conventional technical means by step 4) in formula mixture be prepared into nutrient powder, nutrition emulsion, glue
At least one of wafer, tablet, pill or oral liquid;
Wherein, step 1) -3) order can mutually change.
Finally, the present invention relates to a kind of product prepared by above-mentioned nephrosis tailored version clinical nutrition formula, including nutrient powder,
Nutrition emulsion, capsule, tablet, pill, oral liquid etc..
In above-mentioned preparation method, wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, alcohol extracting concentration, water extraction are dense
Contracting, and integration of drinking and medicinal herbs component powders are made in concentrate progress spray drying;Wherein, the vitamin and fat are respectively by micro-
Encapsulated processing is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, adds 4~6 times of 50~80% second that weight is raw material weight
Alcohol, is soaked, is extracted 2 times, is merged alcohol extract and is concentrated into no alcohol taste;The active compound dregs of a decoction are flung to after ethanol, and it is original to add weight
6~8 times of water of material weight is soaked, and soak is carried out to decoct 30~60min, filtering removes raw material, leaves and takes decoction
Liquid;Merge alcohol extract and decoction liquor after concentration, and it is spray-dried, it is same finally to prepare medicine food with 60~80 mesh sieves point
Derived components powder.
Preferably, what the microencapsulation of the vitamin was handled comprises the following steps that:1) it regard liposoluble vitamin as core
Material, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer are as wall material, high-pressure homogeneous emulsification, and spraying is instantaneous to be dried, with 60~80 mesh sieves
Divide and prepare liposoluble vitamin powder;2) using water soluble vitamin as core, from sodium carboxymethylcellulose, gelatin, OK a karaoke club
Glue, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, chrysanthemum
One or more works in powder, PURE WHEY, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifying agent, stabilizer
For wall material, it is well mixed, spraying is instantaneous to be dried, and water soluble vitamin powder is prepared with 60~80 mesh sieves point.
Preferably, the specific implementation step of the fatty micro-capsule embedding techniques is as follows:By fat, emulsifying agent, wall material with
Water mixed dissolution prepares emulsion;After the stirring mixing of above-mentioned emulsion, emulsifying homogeneous processing is carried out, spraying is then carried out dry
Dry, screening prepares fat powder, and fat powder is compared with conventional grease, and its dispersiveness, water solubility, emulsibility, inoxidizability are all
Improve a lot;Wherein, the emulsifying agent be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
One in sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin, monoglyceride, Tween 80
Plant or a variety of;The wall material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, fat egg
In vain, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean
One or more in fiber, lactose, candy sugar powder, emulsifying agent, stabilizer.
Being used in the present invention includes Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon fruit, Chinese yam, the medicine of oyster
Same derived components are eaten, mentioned component has functions that nourishing liver and kidney, strengthening the essence blood-nourishing.
Fermented Soybean mainly contains protein, fat, carbohydrate, the composition such as vitamin, its isoflavones being rich in tool
There is obvious anti-oxidant, cancer-resisting, prevent angiocardiopathy etc. from acting on, and contained farnoquinone -7 helps to prevent bone
Matter is loose.
Poria cocos can clearing damp and promoting diuresis, have function of invigorating spleen again, transmitting and distributing the fluids be unable to for insufficiency of the spleen, stop the disease that phlegm and retained fluid is given birth in dimerization,
With therapeutic action;Poria cocos energy mental-tranquilization, therefore available for diseases such as confused and worried, palpitaition, insomnias;Poria cocos also has certain resist
Cancer, antitumor action and raising humoral immune function.
Raspberry is the dry fruit of rosaceous plant rubus chingii Hu, with kidney-nourishing, controlling nocturnal emission with astringent drugs, contracting urine effect, for kidney
The treatment of the diseases such as the empty enuresis, frequent urination, impotence and premature ejaculation, emission and spermatorrhea.Raspberry aqueous extract can reduce experimental rat inferior colliculus
Brain LHRH, hypophysis LH, FSH and sexual gland E2 contents, and improve thymus gland LHRH and blood T levels.Research shows raspberry Aqueous extracts
It is probably the pharmacological basis of its " the puckery essence of kidney tonifying " to the regulating and controlling effect of gonad axis.
LBP-X has repair to hepatic injury caused by carbon tetrachloride in matrimony vine, and its mechanism may be by prevention
The damage of matter net, promotes protein synthesis and detoxication, recovers the function of liver cell, and promote liver cell regeneration;Matrimony vine is thick
Polysaccharide can reduce hepatic tissue mda content, and carbon tetrachloride hepatic injury mouse liver glycogen content can be made significantly to raise, and improve human body
Energy reserve;The active ingredient in matrimony vine can improve mitochondrial form to alcoholic liver disease of rats model, mitigate liver simultaneously
The steatosis and inflammation degree of necrosis of cell.
Sealwort has resisting pathogenic microbes effect, and sealwort decoction is given while tulase is infected with significant antibacterial
Effect, and health status can be improved, it has suppression to make to Grain-negative typhoid bacillus and Grain-positive staphylococcus aureus
With;Sealwort methanolic extract can be significantly to the blood glucose rise caused by antiadrenergic drug, with certain blood sugar reducing function;Sealwort
Methanolic extract can substantially increase the convergent force of rat atrial flesh;Sealwort decoction is to triglycerides, beta lipoprotein and cholesterolemia
There is obvious reduction to act on;Sealwort has certain influence to cellular immunity, humoral immunity, can improve lymphocyte transformation rate, be conducive to
The formation of antibody.
Balloonflower root has eliminating the phlegm, antibechic, anti-inflammatory, hypotensive, hypoglycemic, fat-reducing, antitumor, raising body immunity etc. extensively
Pharmacological activity.
There is Gorgon fruit the strong, tonifying middle-Jiao and Qi of nourishing, appetizing to quench the thirst, foster essence etc. of reinforcing the kidney effect;Gorgon fruit can strengthen small intestine suction
Function is received, urine xylose excretion rate is improved, increases serum concentration of carotene, the raising of serum carotenoid levels can make lung cancer, stomach
The morbidity risk rate of cancer declines, and greatly reduces the chance of cancer generation;Gorgon fruit contains abundant starch, can provide heat energy for human body,
And contain multivitamin and carbonizable substance, it is ensured that composition needed for endotrophic.
Chinese yam especially Chinese yam polysaccharide has good immunoregulation effect, and Chinese yam can extend the low mouse of immunity function
The hypoxic tolerance time, improve spleen index, thymus index (P<0.05) thymus gland, the institutional framework of spleen, are improved.
Oyster nutrition liquid energy significantly reduces the blood urea nitrogen and blood lactase acid level of mouse, improves blood lactase acid resume speed, together
When can significantly extend the mice burden swimming time, oyster nutrient solution has antifatigue effect.
Compared with prior art, the invention has the advantages that:
(1) present invention reduces Urine proteins by the nutrition treatment of low protein diet, reduces serium inorganic phosphorus, slows down glomerulosclerosis,
Nourishing liver and kidney, strengthening the essence blood-nourishing integration of drinking and medicinal herbs composition is added simultaneously, each nutritional ingredient complements each other, and determined curative effect can improve
The condition of disease treatment nephrotic, so as to delay the development and deterioration of the state of an illness, improves Quality of Life of Patients, mitigate family and
Burden on society.
(2) present invention also adds of animal or plant nature oligopeptide, and oligopeptide refers to mean molecule quantity for below 1000D, by life
The small molecule protein of thing enzyme engineering technology separation and Extraction from animal or vegetable protein, with it is soluble in water, to acid, heat
Stable the characteristics of, digestion is not required in human body directly to be absorbed, and bioavailability is high.Oligopeptide, which is removed, has corresponding nutrition work(
Can be outer, also with a series of physiological active functionses:Promote the absorption of electrolyte and supplement, anti-sports fatigue, improve immunity, auxiliary
Help the effect such as regulation blood pressure blood fat, anti-oxidant, antitumor, promotion bone growth;And the present invention uses low protein content, it is adapted to kidney
Patient takes.
(3) present invention also addition prebiotics galactooligosaccharide, oligoisomaltose;Prebiotics can promote probiotics enteron aisle
Field planting, enteron aisle convergence, reduction enteron aisle PH environment, promote the growth and breeding of human body beneficial bacteria, so as to suppress corrupt bacteria growing, have
Help improve and maintain enteron aisle normal function;Long-term consumption can improve immunity, mitigate burden of liver, anti-aging, promotion
Defecation.
(4) the vitamin and mineral reference that the present invention is used《Special medicine purposes formula food general rule》Perform there is provided
Water soluble vitamin needed by human, liposoluble vitamin, macroelement and trace element.
(5) present invention also adds Purple Perilla Seed Oil, with fat-reducing, reduction cholesterol, improves the effect such as renal function;In addition
Chain triglyceride, available for treatment hyperplasia of prostate, dissipation cholelith, reduction cholesterol, anti-curing hyperlipemia.
(6) present invention prepares vitamin using micro-capsule embedding techniques, and vitamin is embedded in wall material, can prevent dimension from giving birth to
Element is destroyed by macroelement, trace element, extends the holding time of vitamin;The present invention is prepared using micro-capsule embedding techniques
Powdered oil so that powdered oil has preferable mobility, it is easy to be well mixed with other powdered components;And use micro-capsule bag
Bury after technology, grease is embedded in wall material, so that the contact with air is avoided to strengthen inoxidizability, so as to play guarantor
The maximum effect of strong type grease.
(7) raw material of nephrosis tailored version clinical nutrition of the present invention formula in preparation process it is previously prepared into
150~250 μm of powder, this make it that, when preparing finished product, each nutrition composition can be well mixed, it is ensured that each in unit volume
The content of nutrition composition is essentially identical, while when preparing liquid type preparation, each nutrition composition can be fully dispersed and is completely dissolved
Into solvent, prevent occurring solid precipitation in liquid, effect of finished product product has been effectively ensured.
The present invention is by from rational basal nutrient element, using the proportioning of general equilibrium, while addition has nourishing liver
The specific nutrients such as integration of drinking and medicinal herbs composition, natural plants compound, the new resource food of kidney, strengthening the essence blood-nourishing and strengthen immunity,
And its proportioning and basal nutrient element progress compatibility synergy are adjusted, so that the nutrient formulation of allotment is easier to be disappeared by nephrotic
Change and absorb, give full play to effect of its component, improve the condition of nephrotic, delay progression of disease, improve the quality of living,
Extend the life-span.
Embodiment
The present invention provides a kind of clinical nutrition formula special for nephrosis, including following component and its parts by weight:8-
15 parts of protein, 8-12 parts of fat, 55-65 parts of carbohydrate, 3-5 parts of dietary fibers, 0.5-1.5 parts of part macroelements,
0.01-0.04 parts of part trace elements, 0.005-0.015 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins, 0.05-
1 part of meals elite, 0.05-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-2 portions of new resources foods
Product.
With reference to embodiment, the embodiment to the present invention is further described.Following examples are only used for more
Plus technical scheme is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
The special clinical nutrition formula of nephrosis of the present invention includes PURE WHEY 11.2g, whole milk powder 4g, shell egg
Powder 0.18g, colostrum 0.09g, taurine 0.12g;Soybean oligopeptide 0.1g, ocean fish oligopeptide 0.1g, olive oil 1.58g,
Soybean oil 2.55g, coconut oil 1.58g, perilla herb oil 0.36g, medium chain triglyceride 3.64g;Maltodextrin 43.52g, tapioca
9.45g, cornstarch 7.27g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.53g in macroelement, phosphorus 0.23g,
Potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc 0.016g in trace element;In liposoluble vitamin
Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D30.000001g, vitamin E 0.008g;Water soluble vitamin
Vitamin B in raw element10.001g, vitamin B20.001g, vitamin B60.0002g, vitamin B120.000001g, dimension life
Plain C 0.102g, pantothenic acid 0.003g, folic acid 0.000023g, nicotinic acid 0.0133g;Millet powder 0.1g, mung bean flour 0.1g, white fungus powder
0.1g, broccoli powder 0.1g, salmon powder 0.1g, Fermented Soybean 0.1g, Poria cocos 0.1g, raspberry 0.1g, matrimony vine 0.1g, sealwort
0.1g, balloonflower root 0.1g, Gorgon fruit 0.1g, Chinese yam 0.1g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 2
The special clinical nutrition formula of nephrosis of the present invention includes PURE WHEY 9.1g, whole milk powder 4g, shell egg
Powder 0.18g, colostrum 0.09g, taurine 0.12g, soybean oligopeptide 0.1g, ocean fish oligopeptide 0.1g;Olive oil 1.58g,
Soybean oil 2.55g, coconut oil 1.58g, perilla herb oil 0.36g, medium chain triglyceride 3.64g;Maltodextrin 45.72g, tapioca
9.45g, cornstarch 7.27g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.53g in macroelement, phosphorus 0.23g,
Potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc 0.016g in trace element;In liposoluble vitamin
Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D30.000001g, vitamin E 0.008g;Water soluble vitamin
Vitamin B in raw element10.001g, vitamin B20.001g, vitamin B60.0002g, vitamin B120.000001g, dimension life
Plain C 0.102g, pantothenic acid 0.003g, folic acid 0.000023g, nicotinic acid 0.0133g;Millet powder 0.1g, mung bean flour 0.1g, white fungus powder
0.1g, broccoli powder 0.1g, salmon powder 0.1g, Fermented Soybean 0.1g, Poria cocos 0.1g, raspberry 0.1g, matrimony vine 0.1g, sealwort
0.1g, balloonflower root 0.1g, Gorgon fruit 0.1g, Chinese yam 0.1g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 3
The special clinical nutrition formula of nephrosis of the present invention includes PURE WHEY 11.2g, whole milk powder 4g, shell egg
Powder 0.18g, colostrum 0.09g, taurine 0.12g, soybean oligopeptide 0.1g, ocean fish oligopeptide 0.1g;Olive oil 1.58g,
Soybean oil 2.55g, coconut oil 1.58g, perilla herb oil 0.36g, medium chain triglyceride 3.64g;Maltodextrin 43.52g, tapioca
9.45g, cornstarch 7.27g;Water-soluble dietary fiber 4.55g in dietary fiber;Calcium 0.53g in macroelement, phosphorus 0.23g,
Potassium 0.05g, sodium 0.15g, magnesium 0.15g;Iron 0.011g, iodine 0.00014g, zinc 0.016g in trace element;In liposoluble vitamin
Vitamin A 0.0005g, beta carotene 0.000057g, vitamin D30.000001g, vitamin E 0.008g;Water soluble vitamin
Vitamin B in raw element10.001g, vitamin B20.001g, vitamin B60.0002g, vitamin B120.000001g, dimension life
Plain C 0.102g, pantothenic acid 0.003g, folic acid 0.000023g, nicotinic acid 0.0133g;Millet powder 0.1g, mung bean flour 0.1g, white fungus powder
0.1g, broccoli powder 0.1g, salmon powder 0.1g, Fermented Soybean 0.01g, Poria cocos 0.01g, raspberry 0.01g, matrimony vine 0.01g, Huang
Smart 0.01g, balloonflower root 0.01g, Gorgon fruit 0.01g, Chinese yam 0.01g, l-cn 0.64g, avenabeta glucosan 0.02g.
Embodiment 4
A kind of preparation method of the special clinical nutrition formula of nephrosis as described in 1~embodiment of embodiment 3 is as follows:
1) powdered oil (powder fat) is prepared:
A) the wall material aqueous solution is prepared:Take 8 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, dietary fiber 2
Gram (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, Arabic gum
0.2 gram, 0.5 gram of lactose, 2 grams of candy sugar powder, 50 milliliters of water stirs and (has ready conditions and heat while stirring to 60 DEG C, kept for 30 points
Room temperature is cooled to after clock).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (olive oil in 9.11 milliliters of greases monoglyceride
1.48 milliliters, 2.39 milliliters of soybean oil, 1.48 milliliters of coconut oil, 0.34 milliliter of perilla herb oil, 3.42 milliliters of medium chain triglyceride).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in the wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration is 0.2%) to enter after mixed solution, is settled to water
Disperse 2 minutes at a high speed under 200 milliliters (total solid concentration is 25%), 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) obtained emulsion is spray-dried, EAT is 195 DEG C, leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, add weight be raw material weight 4~6 times of 50~80% ethanol, soaked, extracted 2 times, conjunction
And alcohol extract and it is concentrated into no alcohol taste;The active compound dregs of a decoction are flung to after ethanol, are added weight and are carried out for 6~8 times of water of raw material weight
Immersion, carries out decocting 30~60min, filtering removes raw material, leaves and takes decoction liquor to soak;Merge the alcohol extract after concentration and decoct
Boil liquid, and it is spray-dried, finally prepare integration of drinking and medicinal herbs component powders with 60~80 mesh sieves point;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, from oligomeric different malt
Sugar carries out 2 emulsifying homogeneous processing under high pressure as wall material, and the emulsifying homogeneous time is 10~15min, then carries out spraying wink
When dry, point prepare liposoluble vitamin powder with 60~80 mesh sieves;It regard the water soluble vitamin of predetermined weight number as core
Material, from maltodextrin, oligoisomaltose as wall material, is well mixed, and spraying is instantaneous to be dried, and is prepared with 60~80 mesh sieves point
Water soluble vitamin powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;(step 1) -4) order
Can mutually it change)
5) by step 1)~step 4) obtained by powder sequentially add the mixers of cone-type mixer or other forms and mix
Uniformly obtained formula mixture is closed, it is standby after sterilization processing;
6) according to conventional technical means by step 5) in formula mixture be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral liquid.
In step 6) in, optionally increase appropriate food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, flavoring essence spices, brown sugar;More preferably carragheen, Arabic gum, Guar
Glue, Aspartame, flavoring essence spices.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent production
The danger of green powder blast.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
Embodiment 5
1) influence of nutrient formulation preparation prepared by the present invention to mouse weight;
The nutrient powder for taking the embodiment of the present invention 1~3 to prepare is tested, while setting comparative example 1, comparative example 2 and blank pair
According to group, comparative example 1 uses embodiment 2 using nutrient powder prepared by oligopeptide, comparative example 2 is deleted in the nutrient formulation of embodiment 2
Nutrient formulation in delete nutrient powder prepared by integration of drinking and medicinal herbs composition, blank control group gavage physiological saline.
SPF grades of BALB/C mices, male and female half and half, body weight 28~35g, every group 10.Filled daily according to 0.3g/10g dosage
Stomach mouse, continuous 30 days.Single cage is fed during to mouse stomach, and it is determined daily and takes in appetite, claims 1 body weight within every 3 days, finally
Each group increased weight is calculated, 1 is shown in Table.
The nephrosis tailored version clinical nutrition of table 1 is formulated the influence to mouse weight
Group | First body weight/g | Whole body weight/g | Weightening/g |
Embodiment 1 | 28.3 | 45.4 | 17.1 |
Embodiment 2 | 28.4 | 47.1 | 18.7 |
Embodiment 3 | 29.8 | 46.7 | 16.9 |
Comparative example 1 | 31.2 | 47.8 | 16.6 |
Comparative example 2 | 29.0 | 45.1 | 16.1 |
Control group | 31.9 | 45.8 | 13.9 |
Table 1 understands that the nutrient formulation has no to mouse weight growth and significantly affected, and can maintain the normal physiological work(of mouse
Can, harmful effect is not produced to the normal growth of mouse.
2) therapeutic action of nutrient formulation preparation prepared by the present invention to STZ modeling adriamycin-induced nephropathy in Wistar rats;
The nutrient powder for taking the embodiment of the present invention 2 to prepare is tested, and sets Normal group, diabetic nephropathy model
Group, Captopril group.
Using cleaning grade male SD rat 100, body weight is in 180-200g.With the intraperitoneal note of STZ citron acid solution buffer solutions
Penetrate and prepare Diabetic nephropathy animal model, Normal group intraperitoneal injection equivalent citrate buffer.Inject after 72h, big rat-tail
Vein surveys blood glucose>16.6mmol/L is modeling success, and animal is randomly divided into 5 groups, every group 10 by blood glucose value.
Each group experiment mice is raised, mouse freely ingests and drunk water in experimentation, it is continuous to feed 4 weeks.Leave and take
24h urines, next day femoral artery takes blood, separates serum, and blood, -20 DEG C of Urine specimens preserve standby survey.Rat renal is taken to weigh, on ice bath
Cortex renis is taken, puts fixed in 10% formalin.
Test result indicates that the persistent high blood sugar nutrient powder group feeding that after 4 weeks prepared by Captopril group, the embodiment of the present invention 2
After 4 weeks in blood in Ure, blood Cr (SCr) and urine in mALB/Cr be substantially less than model control group;Test captopril after 4 weeks
Nutrient powder group Pathological prepared by group, the embodiment of the present invention 2, which changes, is substantially lighter than diabetic model group.
Experimental result shows that nutrient formulation of the present invention can improve modeling animal renal function, albuminuria be reduced, to STZ
The early nephropathy of induced diabetes nephrotic rats has significant preventive and therapeutic effect.
From above-described embodiment, various components are worked in coordination in the special clinical nutrition formula of nephrosis of the present invention,
There is provided reasonable, comprehensive nutritional support for nephrotic, to improve the condition of nephrotic, while addition it is nourishing liver and kidney,
Integration of drinking and medicinal herbs composition, natural plants compound and the new resource food of strengthening the essence blood-nourishing and strengthen immunity, delay progression of disease, carry
High quality of life, extends the life-span.
The specific embodiment of the present invention is described in detail above, but it is only used as example, and the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and to replace
In generation, is also all among scope of the invention.Therefore, the equalization made without departing from the spirit and scope of the invention is converted and repaiied
Change, all should be contained within the scope of the invention.
Claims (9)
1. a kind of nephrosis tailored version clinical nutrition formula, it is characterised in that including following component and its parts by weight:8-15 portions of eggs
White matter, 8-12 parts of fat, 55-65 parts of carbohydrate, 3-5 parts of dietary fibers, 0.5-1.5 parts of macroelements, 0.01-0.04 parts
Trace element, 0.005-0.015 parts of liposoluble vitamins, 0.01-0.2 parts of water soluble vitamins, 0.05-1 parts of meals elite,
0.05-2 parts of integration of drinking and medicinal herbs compositions, 0.1-3 parts of natural plants compounds and 0.005-2 parts of new resource foods;
Wherein, the integration of drinking and medicinal herbs composition is selected from Fermented Soybean, Poria cocos, raspberry, matrimony vine, sealwort, balloonflower root, Gorgon fruit, Chinese yam, oyster
At least one of;
Wherein, the protein includes the small protein that mean molecule quantity is below 1000D.
2. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the small molecular protein
Matter is of animal or plant nature oligopeptide, and its parts by weight is 0-1 parts, and it includes soybean oligopeptide and ocean fish oligopeptide.
3. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the integration of drinking and medicinal herbs into
The parts by weight of each component are as follows in point:0~1 part of Fermented Soybean, 0~1 part of Poria cocos, 0~1 part of raspberry, 0~1 part of matrimony vine, sealwort
0~1 part, 0~1 part of balloonflower root, 0~1 part of Gorgon fruit, 0~1 part of Chinese yam, 0~1 part of oyster.
4. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the dietary fiber is equal
For water-soluble dietary fiber, it at least includes bag galactooligosaccharide and oligoisomaltose.
5. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the fat contains purple
0-2 parts of perilla oil, 2-4 parts of medium chain triglyceride.
6. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the natural plants
Compound is selected from l-cn, Glucosamine, FOS, lutein, phytosterol, lycopene, resveratrol, allicin
At least one of.
7. a kind of nephrosis tailored version clinical nutrition formula according to claim 1, it is characterised in that the new resource food
Gather selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, bamboo-leaves flavones, CPP, oat β-Portugal
At least one of sugar, yeast beta-dextran, newborn mineral salt, pueraria root powder, Rosa roxburghii, xylo-oligosaccharide.
8. a kind of preparation method of nephrosis tailored version clinical nutrition formula as claimed in claim 1, it is characterised in that including such as
Lower step:
(1) fat of predetermined weight, liposoluble vitamin, water soluble vitamin are respectively adopted micro-capsule embedding techniques and prepare and cross 60
Powder is made in~80 mesh sieves;
(2) the integration of drinking and medicinal herbs composition of predetermined weight is by crushing, alcohol extracting, water extraction, spray drying and powder is made in 60-80 mesh sieves excessively
End;
(3) remaining component of predetermined weight is prepared into the powder that particle diameter is 150~250 μm respectively;
(4) be mixed can direct pharmaceutical formulation for the powder for preparing step (1)-(3);
Wherein, the order of step (1)-(3) can be changed mutually;The pharmaceutical formulation include nutrient powder, nutrition emulsion, capsule,
Tablet, pill, oral liquid.
9. the preparation method of nephrosis tailored version clinical nutrition formula according to claim 8, it is characterised in that step (2)
The preparation method of integration of drinking and medicinal herbs component powders is as follows:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, add weight be raw material weight 4~6 times of 50~80% ethanol, soaked, extracted 2 times, conjunction
And alcohol extract and it is concentrated into no alcohol taste;The active compound dregs of a decoction are flung to after ethanol, are added weight and are carried out for 6~8 times of water of raw material weight
Immersion, carries out decocting 30~60min, filtering removes raw material, leaves and takes decoction liquor to soak;Merge the alcohol extract after concentration and decoct
Boil liquid, and it is spray-dried, finally prepare integration of drinking and medicinal herbs component powders with 60~80 mesh sieves point.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710516559.3A CN107319524A (en) | 2017-06-29 | 2017-06-29 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710516559.3A CN107319524A (en) | 2017-06-29 | 2017-06-29 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107319524A true CN107319524A (en) | 2017-11-07 |
Family
ID=60198471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710516559.3A Pending CN107319524A (en) | 2017-06-29 | 2017-06-29 | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107319524A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN108013454A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof |
CN108651988A (en) * | 2018-05-10 | 2018-10-16 | 上海奥医生物医药科技有限公司 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
CN110122863A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof improving liver function |
CN110122866A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of the special medicine purposes food and preparation method of chronic kidney disease angiosteosis |
CN110226743A (en) * | 2019-07-05 | 2019-09-13 | 济南大学 | A kind of Adult chronic's kidney trouble nontransparent PCI-PCI bridge wholefood formula and preparation method thereof |
CN110463989A (en) * | 2019-07-24 | 2019-11-19 | 浙江禾健生营养科技有限公司 | A kind of full nutrient formulation powder of nephrosis tailored version and preparation method thereof |
CN111642750A (en) * | 2020-06-13 | 2020-09-11 | 上海复旦奥医医学科技有限公司 | Special clinical nutrition formula food for kidney cancer and preparation method thereof |
CN115054677A (en) * | 2022-03-24 | 2022-09-16 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for patients with nephropathy |
CN115137059A (en) * | 2022-05-23 | 2022-10-04 | 青岛普瑞森医药科技有限公司 | Non-full-nutrition food for improving nephropathy and preparation process thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104187646A (en) * | 2014-08-18 | 2014-12-10 | 胡安然 | Total nutrient formula food for renal failure |
CN104855994A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with nephropathy |
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-06-29 CN CN201710516559.3A patent/CN107319524A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104187646A (en) * | 2014-08-18 | 2014-12-10 | 胡安然 | Total nutrient formula food for renal failure |
CN104855994A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full nutritional formula food for patients with nephropathy |
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
CN106579460A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrition formula for fracture and preparation method thereof |
CN106579393A (en) * | 2016-12-23 | 2017-04-26 | 上海奥医生物医药科技有限公司 | Special clinical nutrient formula for diabetes and preparation method thereof |
CN106666728A (en) * | 2016-12-23 | 2017-05-17 | 上海奥医生物医药科技有限公司 | Special clinical nutrient composition for gestational diabetes and preparation method of nutrient composition |
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106858595A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | One kind burn tailored version clinical nutrition formula and preparation method thereof |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN108013454A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof |
CN108651988A (en) * | 2018-05-10 | 2018-10-16 | 上海奥医生物医药科技有限公司 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
CN110122863A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof improving liver function |
CN110122866A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of the special medicine purposes food and preparation method of chronic kidney disease angiosteosis |
CN110226743A (en) * | 2019-07-05 | 2019-09-13 | 济南大学 | A kind of Adult chronic's kidney trouble nontransparent PCI-PCI bridge wholefood formula and preparation method thereof |
CN110463989A (en) * | 2019-07-24 | 2019-11-19 | 浙江禾健生营养科技有限公司 | A kind of full nutrient formulation powder of nephrosis tailored version and preparation method thereof |
CN111642750A (en) * | 2020-06-13 | 2020-09-11 | 上海复旦奥医医学科技有限公司 | Special clinical nutrition formula food for kidney cancer and preparation method thereof |
CN115054677A (en) * | 2022-03-24 | 2022-09-16 | 大医声科技(北京)有限公司 | Multi-vitamin nutrient formula suitable for patients with nephropathy |
CN115137059A (en) * | 2022-05-23 | 2022-10-04 | 青岛普瑞森医药科技有限公司 | Non-full-nutrition food for improving nephropathy and preparation process thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN101606704B (en) | Dietary fiber food with various functional actions | |
CN102805266B (en) | Feed for improving digestive and immunologic ability of chicken | |
CN102366093A (en) | Composite slimming health food | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN101715913B (en) | Capsule for regulating blood fat and production process thereof | |
CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
KR101539382B1 (en) | Food composition for improvement of bowel function and relief of constipation | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN103445169A (en) | Instant germ mixing powder and preparation method thereof | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN102573523A (en) | Health supplement food, feed, and pharmaceutical composition comprising chia seed and maca, and manufacturing method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171107 |
|
RJ01 | Rejection of invention patent application after publication |